PBYI vs UNH · P/E 4.3, rev $56.5M vs P/E 30, rev $112.03B
Puma Biotechnology Inc (PBYI) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the PBYI and UNH stock pages for the full models.
Not investment advice.